Figure S3 from A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin | Synapse
July 2, 2024Open Access
Figure S3 from A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin
Key Points
Key points are not available for this paper at this time.
Abstract
Figure S3 shows that PBMCs and bispecific antibodies alone are insufficient to kill OVCAR8-Luc cancer cells.